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13 million per year [1]. In Belarus every year nearly 43,000 cases of
cancer are diagnosed among residents of the Republic and cancer
deaths are 17,000 cases per year [2].
Nowadays nanoindentation and atomic force microscopy are
widely used to study various cancers and some important princi-
pal findings have been reported to date. Our research is devoted to
the development of high-performance analytical and experimen-
tal methods to evaluate the physical and mechanical properties
of biomaterials and biological structures based on nanoindenta-
tion techniques and atomic force microscopy (AFM).
Analysis of somemechanical andmathematical models which
are constructed to solve such difficult problems as the choice/
design of mechanical-mathematical model, as the definition the
moment of embedded indenter into an object and accounting of
physical and mechanical properties of biological structures in
the represented techniques on nanoscale level. Adequacy of the
use of fractional order derivatives to construct mechanics–mathe-
maticalmodels of the estimation physical andmechanical proper-
ties of biomaterials is shown in this work [3]. Results of
modifications study due to changes in the physico-mechanical
properties of human cells under lung cancer (adenocarcinoma)
are demonstrated [4]. These changes can be used as biomarker
for tumor cells detection and for determination of therapeutic
strategies in this occurrence for every concrete patient.
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Background: Endometrioid endometrial adenocarcimoma is
the most frequent gynecologic malignancy in the western world.
It is well known that inflammation plays a key role in the initia-
tion and development of cancer as well as promotes both specific
and innate immune response. There is no information on the sta-
tus of the local anti-tumor cellular immunity in endometrioid
adenocarcinoma of the corpus uteri microenvironment in the
Russian and English language medical scientific literature. Vari-
ous studies have shown that high intratumor microvessel density
in endometrial cancer is associated with advanced stage,
increased risk of recurrent disease and with poor prognosis. Vas-
cular endothelial growth factor (VEGF) is a glycoprotein with
potent mitogenic activity. It has been demonstrated to be a key
component in the promotion of angiogenesis.
Materials and methods: There were singlet 24 cases of
endometrioid adenocarcinoma with retrospectively known good
(survival) and poor (death) outcomes. All cases were immunohis-
tochemically stained for CD3, CD20, CD57, CD68, S100, CD34 and
VEGF, expression of was evaluated by IHC-profiler. The number
and the area of vessels was count in ‘‘hot spot” zones and
calculated per 1 mm. For compare of the characteristics of signs
was used comparison of two independent samples – U-Mann–
Whitney test. The level of statistical significance was accepted
by p < 0.05
Results: T-lymphocytes cells were situated predominantly in
desmoplastic stroma of the tumor. CD3 expression was signifi-
cant higher in the group of good outcome (p = 0.00042),
B-lymphocytes cells were predominantly in epithelial component
of tumor. CD20 was expressed in endometriod adenocarcinoma
with good and poor outcome without statistically significant
difference (p = 0.976). NK-lymphocytes were predominantly in
peritumoral stroma. CD57 expression was statistically significant
higher in the group of good outcome (p = 0.000307). Tumor infil-
trating macrophages can were frequent in tumor stroma than
in tumor islets. CD68 expression cells number was higher in the
group with good outcome (p = 0.000219). Dendric cells were pre-
dominantly in epithelial component of tumor. S100+ cells number
did not have any difference (p = 0.105). Inside the tumor stroma,
among pseudo-glands or solid beaches there was a positive reac-
tion for anti-CD34 of numerous microvessels together with
groups of endothelial cells (‘‘hot spot”). The number of intratu-
moral vessels in patients with poor outcome was 141.9 ± 24.7 ves-
sels/mm2, in good outcome patients – 93.8 ± 28.7 vessels/mm2.
The number of the intratumoral vessels in this groups was with
significant statistical different (p = 0.0014). The area of intratu-
moral vessels in good outcome cases was 2799.7 ± 535.7 lm2, poor
outcome cases – 5455,2 ± 448,8 lm2. It was significant statistical
different (p = 0.000014). VEGF was expressed in the cytoplasm of
normal endometrial cells, neoplastic ones, endothelial cells and
stroma. VEGF represents a mitogen for endothelial cells that
induces the formation of lumen’s vessels and also increases vas-
cular permeability and protein extravasation. Expression of VEGF
by cancer cells had significant statistical difference in this groups
of patients (p = 0.0411).
Conclusion: There was a significant reduction in T, NK-cells
and macrophages from patients with poor outcome indicates
the development of local immune deficiency that could certainly
plays an important role in tumor progression endometrioid
carcinoma.
Our study demonstrates that the number and the area of ves-
sels, as part of angiogenesis, represent an important prognostic
factor in outcome of endometrioid endometrial adenocarcinoma.
VEGF expression also is an angiogenic factor which plays a great
role in the prognosis of this tumor.
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